Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CLDI will decline by -31.19% over the next 2 Weeks and hit $0.06 by Thursday, August 13, 2026. In that time frame, CLDI's share price is expected to range between $0.06 and $0.07.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Aug 14, 2026 | 0.94 | 1.08 | 1.22 |
| Aug 13, 2026 | 0.98 | 1.11 | 1.24 |
| Aug 12, 2026 | 1.00 | 1.12 | 1.26 |
| Aug 11, 2026 | 1.06 | 1.19 | 1.33 |
| Aug 10, 2026 | 1.15 | 1.28 | 1.41 |
| Aug 7, 2026 | 1.18 | 1.31 | 1.45 |
| Aug 6, 2026 | 1.20 | 1.34 | 1.47 |
| Aug 5, 2026 | 1.22 | 1.36 | 1.48 |
| Aug 4, 2026 | 1.30 | 1.43 | 1.56 |
| Aug 3, 2026 | 1.39 | 1.52 | 1.66 |
CLDI shares rose +9.86% in Friday, July 31, 2026's trading session, rising from a previous close of $1.49 to move at $1.64. The stock demonstrated notable intraday movement (see CLDI's key stats for a full breakdown), fluctuating between $1.53 and $1.93, a +26.14% trading range. While recent weeks have seen some volatility, CLDI has managed to secure a -11.35% drop over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 454.36K shares changing hands, 310.14K more than the previous session. This amounted to $745.16K in total market activity.
Will CLDI Continue Its Downward Trend?
According to analyst ratings and projections for CLDI, Calidi Biotherapeutics, Inc. shares are anticipated to decrease by -34.59%, potentially reaching $1.22 per share by August 14, 2026. Short-term technical indicators for CLDI currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 19 negative trading days within the past 30 sessions. Based on the CLDI stock forecast, now is not the best time to buy CLDI stock because its current trading price is +52.42% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on CLDI covering social and institutional perspectives.
CLDI Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CLDI's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 36.08% to 39.35%) suggest the stock is in a weak bearish momentum phase. The 50-day RSI, at 36.09%, hints at potential weakness developing in the medium term. Additionally, the 100-day RSI, at 40.48%, maintains a neutral outlook for the long term. Insights into CLDI's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Calidi Biotherapeutics Short-Term Forecasts
CLDI Forecast For Next 5 Days
Our algorithm anticipates Calidi Biotherapeutics (CLDI) stock could hit $0.07 by Aug 07, 2026. This represents a -95.52% fall from today's price, following a -9.81% change over the past five days.
CLDI Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Calidi Biotherapeutics, Inc. (CLDI) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.06, which would mean a -96.34% decrease from the current price of $1.64. Projections for this period range from a high of $0.09 to a low of $0.04.
CLDI Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Calidi Biotherapeutics's price over the next three months point to a drop. CLDI stock is expected to peak at $167.97 on Sep 17, 2026 before potentially dipping to $0.00 on Oct 30, 2026. On average, CLDI is likely to trade around $0.00 in the coming 90 days.
Calidi Biotherapeutics Stock Forecast 2025
Based on our predictive models, Calidi Biotherapeutics (CLDI) is expected to trade between $0.00 and $167.97 throughout 2026. This would result in an average price of $0.00, potentially offering investors a -100.00% return from current levels.
Calidi Biotherapeutics, Inc. Monthly Forecast 2026–2027
August 2026
According to our latest forecast models, Calidi Biotherapeutics, Inc. (CLDI) is positioned to show a strong performance in August 2026. The price is predicted to move between $0.00 and $159.78, settling at an average of $0.00. This could translate to a -100.00% loss.
September 2026
Based on current market signals, Calidi Biotherapeutics, Inc. is projected to trend september 2026. We forecast a trading range from $0.00 to $167.97, with a likely average price of $0.00. Investors could expect a potential return of -100.00%.
October 2026
Our predictive algorithms indicate Calidi Biotherapeutics, Inc. stock may see a shift in October 2026. The expected range spans $0.00–$166.15, with an average target of $0.00. This represents a cautious outlook and a possible loss of -100.00%.
November 2026
Analyzing established trends, Calidi Biotherapeutics, Inc. looks set to move in November 2026. Projections place the stock between $0.00 and $162.25, averaging around $0.00. This suggests a -100.00% loss from current levels.
December 2026
Market indicators suggest Calidi Biotherapeutics, Inc. could experience notable changes during December 2026. Prices could fluctuate within $0.00 to $156.54, with a midpoint forecast of $0.00. The stock might deliver a -100.00% loss.
January 2027
Forecasting for January 2027, models estimate that Calidi Biotherapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $164.04, averaging $0.00. This signals a cautious trajectory with potential returns around -100.00%.
February 2027
According to our latest forecast models, Calidi Biotherapeutics, Inc. (CLDI) is positioned to show a strong performance in February 2027. The price is predicted to move between $0.00 and $166.95, settling at an average of $0.00. This could translate to a -100.00% loss.
March 2027
Based on current market signals, Calidi Biotherapeutics, Inc. is projected to trend march 2027. We forecast a trading range from $0.00 to $160.45, with a likely average price of $0.00. Investors could expect a potential return of -100.00%.
April 2027
Our predictive algorithms indicate Calidi Biotherapeutics, Inc. stock may see a shift in April 2027. The expected range spans $0.00–$150.93, with an average target of $0.00. This represents a cautious outlook and a possible loss of -100.00%.
May 2027
Analyzing established trends, Calidi Biotherapeutics, Inc. looks set to move in May 2027. Projections place the stock between $0.00 and $167.52, averaging around $0.00. This suggests a -100.00% loss from current levels.
June 2027
Market indicators suggest Calidi Biotherapeutics, Inc. could experience notable changes during June 2027. Prices could fluctuate within $0.00 to $163.60, with a midpoint forecast of $0.00. The stock might deliver a -100.00% loss.
July 2027
Forecasting for July 2027, models estimate that Calidi Biotherapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $171.25, averaging $0.00. This signals a cautious trajectory with potential returns around -100.00%.
CLDI's history of dividends and stock splits also plays a role in long-term investor confidence.

